| Literature DB >> 29749980 |
Emadodin Darchini-Maragheh1, Mahdi Balali-Mood1.
Abstract
Chemical warfare agents are the most brutal weapons among the weapons of mass destruction. Sulfur mustard (SM) is a potent toxic alkylating agent known as "the King of the Battle Gases". SM has been the most widely used chemical weapon during the wars. It was widely used in World War I. Thereafter, it was extensively employed by the Iraqi troops against the Iranian military personnel and even civilians in the border cities of Iran and Iraq in the period between 1983 and 1988. Long-term incapacitating properties, significant environmental persistence, lack of an effective antidote, and relative ease of manufacturing have kept SM a potential agent for both terrorist and military uses. Even 3 decades after SM exposure, numerous delayed complications among Iranian victims are still being reported by researchers. The most common delayed complications have been observed in the respiratory tracts of chemically injured Iranian war veterans. Also, skin lesions and eye disorders have been observed in most Iranian SM-exposed war veterans in the delayed phase of SM intoxication. Thus, extensive research has been conducted on Iranian war veterans during the past decades. Nevertheless, major gaps still continue to exist in the SM literature. Part I of this paper will discuss the delayed complications and manifestations of exposure to SM among Iranian victims of the Iran-Iraq conflict. Part II, which will appear in the next issue of Iran J Med Sci, will discuss the long-term management and therapy of SM-exposed patients.Entities:
Keywords: Chemical warfare agents; Delayed complications; Poisoning; Sulfur mustard
Year: 2018 PMID: 29749980 PMCID: PMC5936843
Source DB: PubMed Journal: Iran J Med Sci ISSN: 0253-0716
Estimate of the number of Iranian morbidities and mortalities due to chemical attacks during the Iran–Iraq war
| Number of Iranians exposed to chemical weapons during the war | 1 000 000 people |
| Number of Iranians who received medical care during their heavy exposures to chemical war gases | 100 000 people |
| Iranians killed by the immediate toxic effects of chemical warfare agents | 5500 (3500 people by nerve agents and 2000 people by mustard gas) |
| Total Iranian mortalities due to poisoning by chemical warfare agents during the war | 25 000 |
| Iranians with the chronic effects of chemical warfare agents (not registered and registered) | 40 000–70 000 people |
| Civil Iranians with chronic toxic effects of chemical warfare agents (registered and not registered) | 35 000 people |
History of sulfur mustard (SM) military use in conflicts
| Year | Event | Ref. |
|---|---|---|
| 1917-1918 | First use in World War I by the German army against the soldiers and civilians in France and Belgium (at Ypres). | ( |
| 1919 | United Kingdom used SM against the Red Army of Russia. | ( |
| 1921-1927 | Spain and France used SM against RIF insurgents in Morocco. | ( |
| 1930 | Italy applied SM against Libya. | ( |
| 1934 | Soviet troops used SM against Xinjiang, China. | ( |
| 1935-1936 | Italy breached the Geneva Protocol treaty and began conquest of Abyssinia (Ethiopia) using SM delivered by aircraft spray. | ( |
| 1943 | A cargo ship carrying a large amount of SM exploded in the harbor of Bari, Italy. The gas was disseminated in the area, injuring more than 600 people. | ( |
| 1937-1945 | Japan invaded china and used chemical weapons (including mustard gas, phosgene, and hydrogen cyanide) against China. | ( |
| 1963-1967 | Egypt used phosgene and SM aerial bombs in support of south Yemen against the Yemeni royalist forces during the Yemeni civil war. | ( |
| 1983-1988 | Iraq extensively used SM and nerve agents against Iran. | ( |
| 1988 | Iraqi army killed 5000 Iraqi civilians in Halabja using SM and the nerve agent sarin. | ( |
| 1995 and 1997 | Sudan applied SM against insurgents in the civil war. | ( |
| August 2013 | Chemical weapons were stockpiled in Syria, which were subsequently used against the opposition forces. | ( |
Physiochemical properties of sulfur mustard
| Chemical formulation | C4H8Cl2S |
|---|---|
| Chemical synonyms | Bis (2-chloroethyl) sulfide, 1,1-1thiobis (2-chloroethane); 1-chloro-2-[(2-chloroethyl) thio] ethane; HD, Distilled mustard gas; Yperite, Yellow cross |
| CAS No. | 505–60-2 |
| Color | Colorless, straw color, or pale yellow (pure) to dark brown or black color (impure) |
| Form | Oily liquid (in room temperature). It transforms into aerosols at 105°C |
| Odor | Smell of garlic, horseradish, addled egg or fried vegetables or a mustard-type odor |
| Solubility | Sparingly soluble in water, (water solubility 0.092 g/100 g at 22°C); soluble in organic solvents; lipophilic and highly fat-soluble |
| Melting point | 13–14°C |
| Boiling point | 215–227°C |
| Volatility | 610 mg/m3 at 20°C |
| Specific gravity | 1.27 |
| Vapor pressure | HD: 0.072 mm Hg at 20°C; 0.11 mm Hg at 25°C |
| Liquid density | 1.274 g/mL |
| Vapor density | 5.4 |
| Solid density | 1.37 g/mL |
| Molecular weight | 159.08 |
| Half life | 5 min at 37°C |
| Metabolites | Thiodiglycol, the main metabolite of SM in urine, which can be detected by chromatography with 1ng/mL sensitivity |
| Excretion | The bulk of SM in the body is excreted through the kidneys after conjugation with amino acid lecithin. |
| Antitoxin | No specific antitoxin |
Distribution of the delayed complications of sulfur mustard in various organs in several studies in Iran
| Author (s) | Publication Year | Population | Case Numbers | Distribution of Complications | Ref. No |
|---|---|---|---|---|---|
| Balali-Mood et al. | 1984 (2–28 months after exposure) | Veterans | 236 | Respiratory tract (78%), central nervous system (45%), skin (41%), and eyes (36%) | ( |
| Shirazi and Balali-Mood | 1987 (2 years after exposure) | Veterans | 77 | Lungs (58%), eyes (46%), and skin (38%) | ( |
| Balali-Mood et al. | 1992 (3–9 years after exposure) | Veterans | 1428 | Lungs (90%), skin (88%), eyes (78%), neural system (71%), gastrointestinal system (55%), and hematopoietic system (38%) | ( |
| Khateri et al. | 2003 (13–20 years after exposure) | Veterans, civilians | 34 000 (mild-to-severe exposure) | Lungs (42.5%), eyes (39%), and skin (24.2%) | ( |
| Holisaz et al. | 2003 (14–20 years after exposure) | Veterans | 100 | Skin (94%), eyes (94%), lungs (75%), hematopoietic system (10%), and gastrointestinal system (5%) | ( |
| Balali-Mood et al. | 2005 (16–20 years after exposure) | Veterans | 40 | Lungs (95%), peripheral nerves (77.5%), skin (75%), and eyes (65%) | ( |
| Etezad-Razavi et al. | 2006 (16–20 years after exposure) | Veterans | 40 | Lungs (95%), skin (90%), and eyes (65%) | ( |
| Ghasemi-Boroumand et al. | 2008 (19 years after exposure) | Civilians | 600 | Lungs (45.8%), eyes (37.7%), and skin (31.5%) | ( |
| Namazi et al. | 2009 (17–22 years after exposure) | Veterans | 134 | Lungs (100%), skin (82.84%), and eyes (77.61%) | ( |
| Zojaji and Balali-Mood et al. | 2009 (17–22 years after exposure) | Veterans | 43 | Lungs (95%), peripheral nerves (77%), skin (73%), and eyes (68%) | ( |
Figure 1High-resolution computed tomography of the lungs in a mustard gas-exposed case, 25 years post exposure. Diffuse cylindrical bronchiectasis is observed in the lower lobes of both lungs. (from the private collection of the corresponding author)
Figure 2Air trapping and bronchiectasis in a lung high-resolution computed tomography of a mustard gas-exposed case, 25 years post exposure, consistent with bronchiolitis obliterans. (from the private collection of the corresponding author)
Figure 3Diffuse hyper- and hypopigmentation of the thorax (left) and the low back (right) in an Iranian war veteran, 16 years after wartime exposure to sulfur mustard. The predilection of sulfur mustard to moist areas is remarkable. (from the private slide collection of the corresponding author, taken with permission of the patient).